Terapevticheskii arkhivTerapevticheskii arkhivТерапевтический архив0040-36602309-5342LLC Obyedinennaya Redaktsiya32002Editorial articleПередовая статьяResearch ArticleSubcutaneous panniculitis-like T-cell lymphoma: The authors’ experience of diagnosis and treatmentПодкожная панникулитоподобная Т-клеточная лимфома. Собственный опыт в диагностике и леченииGorodetskiyV RГородецкийВ РProbatovaN AПробатоваН АVasilyevV IВасильевВ ИMukhortovaO VМухортоваО ВAslanidiI PАсланидиИ ПSidorovaYu VСидороваЮ ВRyzhikovaN VРыжиковаН ВRadenska-lopovokS GРаденска-лоповокС ГEgorovaO NЕгороваО ННИИ ревматологии им. В.А. НасоновойРоссийский онкологический научный центр им. Н.Н. БлохинаНаучный центр сердечно-сосудистой хирургии им. А.Н. БакулеваГематологический научный центр Минздрава России15072016887VOL 88, NO7 ()ТОМ 88, №7 (2016)495510042020Copyright ©; 2016, Consilium MedicumCopyright ©; 2016, ООО "Консилиум Медикум"2016Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://ter-arkhiv.ru/0040-3660/article/view/32002

The paper gives the data of clinical, histological, immunohistochemical, and molecular studies and the results of positron emission tomography in 3 cases of subcutaneous panniculitis-like T-cell lymphoma (SPTCL). It shows the high efficiency of a GEM-P regimen in the treatment of patients with SPTCL.

Аннотация В статье приведены данные клинических, гистологических, иммуногистохимических, молекулярных исследований и результаты позитронно-эмиссионной томографии (ПЭТ) 3 случаев подкожной панникулитоподобной Т-клеточной лимфомы (ППТКЛ). Показана высокая эффективность схемы GEM-P для лечения больных с ППТКЛ.

subcutaneous panniculitis-like T-cell lymphomapositron emission tomographytreatmentподкожная панникулитоподобная Т-клеточная лимфомапозитронно-эмиссионная томографиялечениеGonzalez CL, Medeiros LJ, Braziiel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15(1):17-27. doi:10.1097/00000478-199101000-00002Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer. 2004;101(6):1404-1413. doi:10.1002/cncr.20502Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-3785. doi:10.1182/blood-2004-09-3502Jaffe ES, Gaulard P, Ralfkiaer E et al. Subcutaneous panniculitis-like T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL et al., eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed: Lyon: IARC; 2008:294-295.Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, Canninga-van Dijk MR, Carlotti A, Geerts ML, Hahtola S, Hummel M, Jeskanen L, Kempf W, Massone C, Ortiz-Romero PL, Paulli M, Petrella T, Ranki A, Peralto JL, Robson A, Senff NJ, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ; EORTC Cutaneous Lymphoma Group. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838-845. doi:10.1182/blood-2007-04-087288Parveen Z, Thompson K. Subcutaneous panniculitis-like T-cell lymphoma redefinition of diagnostic criteria in the recent World Health Organization - European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. Arch Pathol Lab Med. 2009;133(2):303-308. doi:10.1043/1543-2165-133.2.303Oschlies I, Simonitsch-Klupp I, Maldyk J, Konovalov D, Abramov D, Myakova N, Lisfeld J, Attarbaschi A, Kontny U, Woessmann W, Klapper W. Subcutaneous panniculitis-like T-cell lymphoma in children - a detailed clinico-pathological description of 11 multifocal cases: high frequence of hemophagocytic syndrom. Br J Dermatol. 2015;172(3):793-797. doi:10.1111/bjd.13440Lozzi GP, Massone C, Citarella L, Kerl H, Cerroni L. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma. Am J Dermatopathol. 2006;28(1):9-12. doi:10.1097/01.dad.0000187933.87103.03Kadin ME. Genetic and molecular genetic studies in the diagnosis of T-cell malignancies. Hum Pathol. 2003;34(4):322-329. doi:10.1053/hupa.2003.94Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, Du X, Shi DR. Subcutaneous panniculitis-like T-cell lymphoma. A clinicopathologic, immunophenotypic, and molecular study of 22 asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008;32(10):1495-1502. doi:10.1097/PAS.0b013e31817a9081van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317. doi:10.1038/sj.leu.2403202Sandberg Y, van Gastel-Mol EJ, Verhaaf B, Lam KH, van Dongen JJ, Langerak AW. BIOMED-2 multiplex immunoglobulin / T-cell receptor polymerase chain reaction protocols can reliably replace southern blot analysis in routine clonality diagnostics. J Mol Diagn. 2005;7(4):495-503. doi:10.1016/S1525-1578(10)60580-6Cerroni L, Gatter K, Kerl H. Subcutaneous «panniculitis-like» T-cell lymphoma. In: Skin Lymphoma.The illustrated guide to guide. 3th ed: Wiley-Blackwell Publishing; 2009:87-96.Lee DW, Yang JH, Lee SM, Won CH, Chang S, Lee MW, Choi JH, Moon KC. Subcutaneous panniculitis-like T-cell lymphoma: A clinical and pathologic study of 14 Korean patients. Ann Dermatol. 2011;23(3):329-337. doi:10.5021/ad.2011.23.3.329Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, Du X, Shi DR. Subcutaneous panniculitis-like T-cell lymphoma: A clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008;32(10):1495-1502. doi:10.1097/PAS.0b013e31817a9081Rodriguez VR, Joshi A, Peng F, Rabah RM, Stockmann PT, Savaşan S. Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma. Pediatr Blood Cancer. 2009;52(3): 406-408. doi:10.1002/pbc.21805Babb A, Zerizer I, Naresh KN, Macdonald D. Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT. Am J Hematol. 2011;86(4):375-376. doi:10.1002/ajh.21874Uematsu T, Kasami M. 3T-MRI, elastography, digital mammography, and FDG-PET CT findings of subcutaneous panniculitis-like T-cell lymphoma (SPTCL) of the breast. Jpn J Radiol. 2012;30(9):766-771. doi:10.1007/s11604-012-0112-5Kim JS, Jeong YJ, Sohn MH, Jeong HJ, Lim ST, Kim DW, Kwak JY, Yim CY. Usefulness of F-18 FDG PET/CT in subcutaneous panniculitis-like T cell lymphoma: disease extent and treatment response evaluation. RadiolOncol. 2012;46(4):279-283. doi:10.2478/v10019-012-0017-zMitsuhashi K, Momose M, Masuda A, Tsunemi Y, Motoji T.Positron emission tomography revealed diffuse involvement of the lower legs and occult extracutaneous lesions in subcutaneous panniculitis-like T-cell lymphoma. Clin Nucl Med. 2013;38(3):209-211. doi:10.1097/RLU.0b013e31827087caLester L, Ewalt M, Warnke R, Kim J. Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis. J Cutan Pathol. 2015;42(1):46-49. doi:10.1111/cup.12436Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O’Doherty MJ, Hustinx R, Biggi A, Cheson BD. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048-3058. doi:10.1200/JCO.2013.53.5229Tsukamoto Y, Katsunobu Y, Omura Y, Maeda I, Hirai M, Teshima H, Konishi Y, Inoue T, Sato T. Subcutaneous panniculitis-like T-cell lymphoma: successful initial treatment with prednisolone and cyclosporin A. Intern Med. 2006;45(1):21-24. doi:10.2169/internalmedicine.45.1433Iqbal N, Raina V. Successful treatment of disseminated subcutaneous panniculitis-like T-cell lymphoma with single agent oral cyclosporine as a first line therapy. Case Rep Dermatol Med. 2014. doi:10.1155/2014/201836Quintanilla-Martinez L, Jansen PM, Kinney MC, Swerdlow SH, Willemze R. Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for hematopathology/european association for haematopathology workshop. Am J Clin Pathol. 2013;139(4):491-514. doi:10.1309/AJCP83AOQTMLOJTMNg M, Waters J, Cunningham D, Chau I, Horwich A, Hill M, Norman AR, Wotherspoon A, Catovsky D. Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma. Br J Cancer. 2005;92(8):1352-1357. doi:10.1038/sj.bjc.6602514Arkenau HT, Chong G, Cunningham D, Watkins D, Sirohi B, Chau I, Wotherspoon A, Norman A, Horwich A, Matutes E. Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica. 2007;92(2):271-272. doi:10.3324/haematol.10737Yim KL, Ashley S. Assessment of gemcitabine, cisplatin and methylprednisolone (GEM-P) combination treatment for non-Hodgkin T cell lymphoma. Med Oncol. 2012;29(5):3535-3539. doi:10.1007/s12032-012-0309-6Velez NF, Ishizawar RC, Dellaripa PF, Saavedra AP, Laga AC, Murphy GF, Fisher DC, Kupper TS, Vleugels RA. Full facial edema: a novel presentation of subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol. 2012;30(25):e233-236. doi:10.1200/JCO.2011.40.7684